Merriman Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,373	Closed	-$283K	–	222
2024 Q3	$283K	Buy	2,373 +48	+2%	+$5.72K	0.01%	175
2024 Q2	$332K	Buy	2,325 +145	+7%	+$20.7K	0.01%	163
2024 Q1	$282K	Buy	2,180 +189	+9%	+$24.4K	0.01%	171
2023 Q4	$206K	Buy	+1,991	New	+$206K	0.01%	177